fbpx

New trial tests clemastine and metformin for MS

New clinical trial will test diabetes drug and antihistamine for MSPublished 26 April 2022 A new clinical trial is taking place which will test to see if taking diabetes drug metformin, and antihistamine drug clemastine, could be used to help repair myelin in people with multiple sclerosis (MS).   Laboratory
Read More

Childhood abuse increases MS risk

Childhood abuse increases MS riskPublished 07 April 2022 Suffering trauma in childhood may increase the risk of developing multiple sclerosis (MS) in women in later life, according to a new study. Experts know that abuse and neglect in childhood are associated with a higher risk of poor mental and physical
Read More

Smell test might predict DMT affectiveness

Smell test might help predict DMT effectivenessPublished 04 April 2022 A smell test could be used to tell whether treatments for multiple sclerosis (MS) are working or not, a new study suggests. Researchers in Austria teste whether measuring olfactory threshold (OT) could be a way to detect whether a person
Read More

The course that helped with MS depression

The course that helped with MS depressionPublished 29 march 2022 A new report from Australia has found an eight-week online course lowered levels of depression and improved life quality in people with multiple sclerosis. Researchers at the University of Sydney created an eight-week course with five interactive sessions. These were
Read More

Hormone therapy, MS and menopause

Hormone therapy, MS and menopausePublished 18 March 2022 What role in a woman’s hormones, and in particular, the hormone changes during the menopause, play in the progression of multiple sclerosis (MS)? At the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Forum 2022, Dr Burcu Zeydan, assistant professor
Read More

Bladder and Bowel Community issue plea

Bladder and Bowel Community issue pleaPublished 15 March 2022 People living with multiple sclerosis (MS) can often have issues with their bladder and bowel function, so much so that even leaving the house can cause extreme anxiety. In March 2021, the Bladder and Bowel Community announced the launch of the
Read More

New report highlights lack of MS nurses

New report highlights lack of MS nursesPublished 15 March 2022 Eighty percent of people with multiple sclerosis (MS) are missing out on the essential care and support they need because they are looked after by specialist nurses with too many people on their books according to a new report. The
Read More

This diet may lower the risk of multiple sclerosis

This diet may lower the risk of multiple sclerosisPublished 22 February 2022 A new study from Iran suggests that eating a diet high in green leafy vegetables, nuts, beans and berries may lower the risk of getting multiple sclerosis (MS). The research team looked at whether the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet
Read More

New drug for MS approved in Scotland

New drug for MS approved in ScotlandPublished 22 February 2022 Vumerity (diroximel fumarate) has been approved for use on the NHS for people with multiple sclerosis (MS). Vumerity is taken orally as a tablet twice a day. It is as effective as Tecfidera (dimethyl fumarate) but doesn’t cause as many stomach problems.
Read More

MS may raise risk of long Covid

MS may raise the risk of long CovidPublished 22 February 2022 A new study has found that almost a third of people with multiple sclerosis (MS) who get Covid-19 have symptoms lasting for at least a month. Researchers reviewed more than 550 cases of people infected with Covid-19 who have MS, none of whom
Read More